Insulet Corporation
PODD Healthcare Medical Devices
Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow PODD
Insulet Corporation (PODD) Total debt
Insulet Corporation's total debt at the end of fiscal 2025 was $949.2M, down 31.2% from $1.4B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $948.4M. Over the past ten years it has ranged from $172.0M (fiscal 2015) to $1.4B (fiscal 2023); the current reading is higher than 55% of that period. Insulet Corporation ranks 20th of 147 Medical Devices companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $949.2M | (31.21%) |
| FY2024 | $1.4B | (2.54%) |
| FY2023 | $1.4B | 1.00% |
| FY2022 | $1.4B | 10.04% |
| FY2021 | $1.3B | 20.26% |
| FY2020 | $1.1B | 18.77% |
| FY2019 | $891.9M | 50.66% |
| FY2018 | $592.0M | 4.56% |
| FY2017 | $566.2M | 70.14% |
| FY2016 | $332.8M | 93.51% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $948.4M | 0.03% |
| Mar 2026 | $948.1M | (0.12%) |
| Dec 2025 | $949.2M | (6.46%) |
| Sep 2025 | $1.0B | (27.50%) |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $3.2B |
| BRKR Bruker Corporation compare | $1.8B |
| BIO.B Bio-Rad Laboratories, Inc. compare | $1.2B |
| BIO Bio-Rad Laboratories, Inc. compare | $1.2B |
| HAE Haemonetics Corporation compare | $1.2B |
| PODD Insulet Corporation | $948.4M |
| GMED Globus Medical, Inc. compare | $443.4M |
| GKOS Glaukos Corporation compare | $67.3M |
| PEN Penumbra, Inc. compare | $19.6M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on PODD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement